
Conference: Asembia AXS25 Summit
日付: April 27 – May 1
エリア: Las Vegas, Nevada
Booth: #1523
Meet us there
Stop by Booth #1523 to speak with members of our team about your upcoming projects and any Patient Services program needs.
医薬品開発のプロセスを大幅に改善しませんか。分子探索から上市に至るまでのお客様の課題を解決するために、科学、技術、戦略、規制に関する専門知識をサターラの専門家が惜しみなく提供します。
詳細はこちらサターラのソフトウェアソリューションは標準規格に準拠しながら、医薬品開発の全フェーズにおいて革新的なアプローチを提供します。高度なモデリング、解析、自動化を実現し、ワークフローの改善と薬事承認の道のりをサポートします。
全て見る御社だけの特別かつ柔軟なサービスで医薬品開発を変革します。予測モデリングからマーケットアクセス戦略まで、サターラのサービスは意思決定の強化とプロセス改善を支援し、貴社の新薬承認をより確実なものにします。
全て見るHome / Conference / Asembia AXS25 Summit
Conference: Asembia AXS25 Summit
日付: April 27 – May 1
エリア: Las Vegas, Nevada
Booth: #1523
Characterized by high costs, more severe side effect profiles, and complex treatment regimens, specialty drugs have long since eclipsed traditional medications in driving biopharma market growth. In 2023, specialty therapies accounted for over 80% of the 55 novel drugs approved by the U.S. FDA. A constellation of patient services and vendors materialized in response to this shift, as biopharma companies worked to ensure patients could overcome a variety of barriers to initiating and adhering to therapy.
Today, the challenge is implementing a patient services program that aligns with patient needs, and is well received by health care providers and other stakeholers. Programs must accurately map to friction points in the patient journey, help differentiate your patient experience in the market and provide a return on your investment.
Patient Services Strategy is the latest offering available as part of Certara’s integrated approach to market access, pricing and reimbursement.
Stop by Booth #1523 to speak with members of our team about your upcoming projects and any Patient Services program needs.
Stop by Booth #1523 to speak with members of our team about your upcoming projects and any Patient Services program needs.
© 2025 Certara. All Rights Reserved. | 個人情報保護